BPS - Board of Pharmacy Specialties Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • BPS - Board of Pharmacy Specialties's estimated annual revenue is currently $29.3M per year.(i)
  • BPS - Board of Pharmacy Specialties's estimated revenue per employee is $201,000

Employee Data

  • BPS - Board of Pharmacy Specialties has 146 Employees.(i)
  • BPS - Board of Pharmacy Specialties grew their employee count by 9% last year.

BPS - Board of Pharmacy Specialties's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.7M31-14%N/AN/A
#2
$7.2M366%N/AN/A
#3
$17.7M8840%N/AN/A
#4
$28.7M1435%N/AN/A
#5
$1.4M7N/AN/AN/A
#6
$15.3M761%N/AN/A
#7
$596.4M29679%N/AN/A
#8
$5.4M27-10%N/AN/A
#9
$86.8M4327%N/AN/A
#10
$5M254%N/AN/A
Add Company

What Is BPS - Board of Pharmacy Specialties?

The Board of Pharmacy Specialties (BPS) was established in 1976 as an autonomous division of the American Pharmacists Association (APhA). The mission of the Board of Pharmacy Specialties is to improve patient care and increase awareness of the need for BPS Board Certified Pharmacists as integral members of multidisciplinary healthcare teams through recognition and promotion of specialized training, knowledge, and skills in pharmacy and specialty board certification and recertification of pharmacists throughout the world. Board Certification through BPS has become recognized as the gold standard for determining which pharmacists are qualified to contribute at advanced practice levels. Through the rigorous standards mandated by BPS board certification and recertification, the BPS board certified pharmacist stands out as the most qualified to accept today’s expanding professional expectations.

keywords:N/A

N/A

Total Funding

146

Number of Employees

$29.3M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$24.1M1466%N/A
#2
$28.9M1466%N/A
#3
$28.9M1467%N/A
#4
$15M1465%N/A
#5
$43.4M1465%N/A